ClinicalTrials.gov record
Recruiting Phase 2 Interventional

Neurovascular Transduction During Exercise in Chronic Kidney Disease

ClinicalTrials.gov ID: NCT02947750

Public ClinicalTrials.gov record NCT02947750. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 10:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease

Study identification

NCT ID
NCT02947750
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Emory University
Other
Enrollment
150 participants

Conditions and interventions

Interventions

  • 6R-BH4 Drug
  • 6R-BH4 placebo Other
  • Exercise training Other
  • Folic acid Dietary Supplement
  • Histidine and beta-alanine placebo Other
  • Histidine and beta-alanine supplementation Dietary Supplement
  • Stretching Other

Drug · Other · Dietary Supplement

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2016
Primary completion
Apr 29, 2027
Completion
Apr 29, 2027
Last update posted
May 17, 2026

2016 – 2027

United States locations

U.S. sites
3
U.S. states
1
U.S. cities
2
Facility City State ZIP Site status
Emory University Hospital Midtown Atlanta Georgia 30308 Recruiting
Emory University Hospital Atlanta Georgia 30322 Recruiting
Atlanta VA Health Care System Decatur Georgia 30033 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02947750, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 17, 2026 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02947750 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →